FDA 安全性情報／クラリスロマイシン
FDA Drug Safety Communication: FDA review finds additional data supports the potential for increased long-term risks with antibiotic clarithromycin (Biaxin) in patients with heart disease (URL)
出典）FDA ＞Drug Safety and Avalilability (URL)
